Disclosure Of First-Time Adoption [Text Block]

Captor Therapeutics S.A. - Filing #6272138

Concept	2020-01-01 to 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	2020-01-01 to 2020-12-31	As at 2020-12-31	As at 2020-12-31	2020-01-01 to 2020-12-31	As at 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2019-01-01 to 2019-12-31	As at 2019-12-31	2019-01-01 to 2019-12-31	As at 2019-12-31	As at 2019-12-31	2019-01-01 to 2019-12-31	2019-01-01 to 2019-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31	2019-01-01 to 2019-12-31	As at 2019-12-31	2019-01-01 to 2019-12-31	2019-01-01 to 2019-12-31	As at 2019-01-01	As at 2019-01-01	As at 2019-01-01	As at 2019-01-01	As at 2019-01-01	As at 2019-01-01	As at 2019-01-01
Disclosure of first-time adoption [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of comparative information prepared under previous GAAP [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of comparative information prepared under previous GAAP [abstract]
Disclosure of comparative information prepared under previous GAAP [line items]
Equity	—	49 830 702 PLN	0 PLN	143 404 751 PLN	136 000 PLN	—	4 003 703 PLN	89 434 346 PLN	—	143 404 751 PLN	—	—	—	—	—	79 129 831 PLN	—	0 PLN	4 003 500 PLN	—	—	79 129 831 PLN	89 433 646 PLN	14 444 015 PLN	—	136 700 PLN	—	—	2 599 932 PLN	136 700 PLN	89 433 646 PLN	10 278 378 PLN	81 891 900 PLN	0 PLN	81 891 900 PLN
Comprehensive income	64 274 919 PLN	—	—	—	—	64 274 716 PLN	—	—	203 PLN	—	0 PLN	0 PLN	0 PLN	64 274 919 PLN	2 454 PLN	—	4 163 183 PLN	—	—	4 165 637 PLN	0 PLN	—	—	—	4 163 183 PLN	—	0 PLN	0 PLN	—	—	—	—	—	—	—
Profit (loss)	64 274 716 PLN	—	—	—	—	64 274 716 PLN	—	—	0 PLN	—	0 PLN	0 PLN	0 PLN	64 274 716 PLN	0 PLN	—	4 165 637 PLN	—	—	4 165 637 PLN	0 PLN	—	—	—	4 165 637 PLN	—	0 PLN	0 PLN	—	—	—	—	—	—	—